Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002-2003: Results of the multinational GRASP Surveillance Program

International Journal of Antimicrobial Agents

Volumn 25, Issue 2, 2005, Pages 148-156

  Beekmann, Susan E ^a   Heilmann, Kris P ^a   Richter, Sandra S ^a   García De Lomas, Juan ^b   Doern, Gary V ^a  

^a Medical Microbiology Division   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antimicrobial resistance; Community acquired respiratory tract infections; Group A streptococcus; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFDINIR; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENZYME SYNTHESIS; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; INTERNATIONALITY; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 12344274527     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.09.016     Document Type: Article

References (19)

1. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: Approved Standard M100-S14. Wayne, PA: NCCLS; 2004.
2. D.K. Chen, A. McGeer, J.C. de Azavedo, and D.E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada Canadian Bacterial Surveillance Network N Engl J Med 341 1999 233 239
3. R. Leclercq, and P. Courvalin Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria Antimicrob Agents Chemother 35 1991 1267 1272
4. S. Kohno, D.J. Hoban The PROTEKT Surveillance Study Group Comparative in vitro activity of telithromycin and B-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT J Chemother 15 2003 335 341
5. B. Bozdogan, P.C. Appelbaum, and L.M. Kelly Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers Clin Microbiol Infect 9 2003 653 661
6. M.E. Jones, R.S. Blosser-Middleton, I.A. Critchley, J.A. Karlowsky, C. Thornsberry, and D.F. Sahm In vitro susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001 Clin Microbiol Infect 9 2003 590 599
7. D.J. Hoban, G.V. Doern, A.C. Fluit, M. Roussel-Delvallez, and R.N. Jones Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program Clin Infect Dis 32 2001 S81 S93
8. M.R. Jacobs, D. Felmingham, P.C. Appelbaum, R.N. Gruneberg The Alexander Project Group The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents J Antimicrob Chemother 52 2003 229 246
9. G.V. Doern, K.P. Heilmann, H.K. Huynh, P.R. Rhomberg, S.L. Coffman, and A.B. Brueggemann Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since Antimicrob Agents Chemother 45 2001 1721 1729
10. L.D. Liebowitz, M. Slabbert, and A. Huisamen National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents J Clin Pathol 56 2003 344 347
11. R. Canton, E. Loza, M.I. Morosini, and F. Baquero Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000 J Antimicrob Chemother 50 2002 9 24
12. J. Shackcloth, L. Williams, and D.J. Farrell Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators J Infect 48 2004 229 235
13. B. Bozdogan, P.C. Appelbaum, and L.M. Kelly Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe Clin Microbiol Infect 9 2003 741 745
14. S. Ioannidou, P.T. Tassios, and L. Zachariadou In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities Clin Microbiol Infect 9 2003 704 707
15. P.R. Hsueh, L.J. Teng, and C.M. Lee Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data Antimicrob Agents Chemother 47 2003 2152 2157
16. J.I. Alos, B. Aracil, J. Oteo, J.L. Gomez-Garces Spanish Group for the Study of Infection in the Primary Health Care Setting Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin- susceptible (M phenotype) Streptococcus pyogenes in Spain J Antimicrob Chemother 51 2003 333 337
17. R.R. Reinert, R. Lutticken, A. Bryskier, and A. Al-Lahham Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during Antimicrob Agents Chemother 47 2003 489 493
18. G. Zhanel, L. Palatnick, K.A. Nichol, D.E. Low, D.J. Hoban The CROSS Study Group Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002 Antimicrob Agents Chemother 47 2003 1875 1881
19. R. Reynolds, J. Shackcloth, D. Felmingham, and A. MacGowan Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme J Antimicrob Chemother 52 2003 931 943